11. Co-Morbidity and IBD

Understanding of the effects of concurrent medical conditions on the treatment of IBD


Full content only available after log-in


11.1.  Knows the importance of assessing co-morbidities in patients with IBD

11.2.  Knows the risks relating to a previous history of malignancy or the development of malignancy in IBD, in particular how this affects treatment options.

11.3.  Knows the risks relating to infections such as tuberculosis, hepatitis B, hepatitis C and HIV in relation to the treatment of IBD

11.4.  Knows the circumstances in which patients should be screened for or immunised against infectious diseases before commencing therapy

11.5.  Is aware of the appropriate investigations and vaccination strategy for patients with a new diagnosis of IBD


The use of IBD medicine in patients with cancer: Which treatment should be stopped when cancer is diagnosed? Which treatment to use in a patient with a prior diagnosis with cancer?

L Beaugerie

ECCO 2017 Barcelona Congress

Webcast + PPT

Topic 11.2 : State of the art